These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6487502)

  • 1. Xipamide: no advantage over bendrofluazide in hypertension.
    Ramsay LE; Freestone S
    Br J Clin Pharmacol; 1984 Oct; 18(4):616-8. PubMed ID: 6487502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the hypotensive effects of bendrofluazide, bumetanide and xipamide.
    Gabriel R
    Curr Med Res Opin; 1983; 8(9):645-8. PubMed ID: 6667628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies covering combined treatments with xipamide. Results of a long-term antihypertensive treatment.
    Heimsoth VH
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):260-6. PubMed ID: 881278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily administration of low-dose xipamide: a long-term study in mild to moderate hypertension.
    Brochez A; Castro M; Odegaard A; Thomis J
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):394-8. PubMed ID: 6354942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of xipamide in the treatment of hypertension.
    Lentini S; Antonelli S; Leone G; Paoletti V
    J Int Med Res; 1980; 8(1):38-43. PubMed ID: 6987114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A log-dose-response study of xipamide and its effect on metabolic parameters.
    Owens CW; Tomlinson B; Liu JB; Graham BR; Gillham C; Smith CC; Betteridge DJ; Prichard BN
    J Hypertens Suppl; 1989 Dec; 7(6):S320-1. PubMed ID: 2632732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Prichard BN; Brogden RN
    Drugs; 1985 Oct; 30(4):313-32. PubMed ID: 3905333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nadolol in combination with indapamide and xipamide in resistant hypertensives.
    Dean S; Kendall MJ; Potter S; Thompson MH; Jackson DA
    Eur J Clin Pharmacol; 1985; 28(1):29-33. PubMed ID: 3987783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antihypertensive activities of xipamide and chlorthalidone: a double-blind, randomized, crossover trial.
    Bonaduce D; Ferrara N; Petretta M; Canonico V; Romango E; Rengo F
    Curr Med Res Opin; 1981; 7(4):247-52. PubMed ID: 7014105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Xipamide in the treatment of mild to moderate systemic arterial hypertension].
    Ramos NB; Guimarães AC
    Arq Bras Cardiol; 1984 Jul; 43(1):71-5. PubMed ID: 6395840
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What did the ALLHAT study bring? To do the one without foregoing the other].
    MMW Fortschr Med; 2003 Dec; 145(51-52):36-7. PubMed ID: 14974327
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical model of the time-course of essential hypertension blood pressure changes during chronic xipamide treatment.
    Castro M; Reyes AJ
    Curr Med Res Opin; 1980; 6(8):523-7. PubMed ID: 7389383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of treatment of hypertension in elderly patients in primary care.
    Coope J; Warrender TS
    Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1145-51. PubMed ID: 3094811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xipamide in the management of renal, hepatic and cardiac oedema.
    Gold CH; Viljoen M
    S Afr Med J; 1978 Sep; 54(14):569-71. PubMed ID: 366781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.